Karin Niepsch
About
In The Last Decade
Karin Niepsch
13 papers receiving 583 citations
Peers
Comparison fields: 5 of 33
- Oncology 359
- Radiology, Nuclear Medicine and Imaging 329
- Epidemiology 291
- Pulmonary and Respiratory Medicine 279
- Neurology 198
Countries citing papers authored by Karin Niepsch
This map shows the geographic impact of Karin Niepsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Niepsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Niepsch more than expected).
Fields of papers citing papers by Karin Niepsch
This network shows the impact of papers produced by Karin Niepsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Niepsch. The network helps show where Karin Niepsch may publish in the future.
Co-authorship network of co-authors of Karin Niepsch
This figure shows the co-authorship network connecting the top 25 collaborators of Karin Niepsch. A scholar is included among the top collaborators of Karin Niepsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Niepsch. Karin Niepsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 104 | |
| 2 | 32 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Progressive Grade 3 Neuroendocrine Neoplasms (NEN) | 1 |
| 8 | 97 | |
| 9 | 112 | |
| 10 | 82 | |
| 11 | 150 | |
| 12 | PSMA radioligand therapy (PRLT) of metastatic castration-resistant prostate cancer: first results using the PSMA Inhibitor 617 | 3 |
| 13 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.